Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

PPL Stock Underperforms its Industry in Three Months: How to Play?
PPL Stock Underperforms its Industry in Three Months: How to Play?

PPL Corp. PPL shares have gained 2.5% in the last three months compared with the Zacks Utility-Electric Power industry’s rally of 5.2%. In the same period, PPL also underperformed the Zacks Utilitie

Gap vs. Urban Outfitters: Which Fashion Titan Leads the Race?
Gap vs. Urban Outfitters: Which Fashion Titan Leads the Race?

In the ever-evolving landscape of fashion retail, two names have consistently shaped trends and defined generations: The Gap Inc. GAP and Urban Outfitters Inc. URBN. GAP is a legacy brand synonymous

CAG Trading Cheaper Than Industry: What's Next for Investors?
CAG Trading Cheaper Than Industry: What's Next for Investors?

Conagra Brands, Inc. CAG, one of North America's leading branded food companies, currently trades at a forward 12-month price-to-earnings ratio of 9.68X. The figure is below the industry and the S&P

SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System

Stryker SYK recently received FDA clearance for its OptaBlate BVN Basivertebral Nerve Ablation System (OptaBlate BVN), a significant milestone in the treatment of chronic vertebrogenic lower back

NVIDIA vs. Super Micro: Which AI Hardware Stock Should You Bet On?
NVIDIA vs. Super Micro: Which AI Hardware Stock Should You Bet On?

The artificial intelligence (AI) revolution has ignited a race among hardware suppliers, and two of the most prominent names riding this wave are NVIDIA Corporation NVDA and Super Micro Computer

IHS Holding (IHS) Q1 Earnings Lag Estimates
IHS Holding (IHS) Q1 Earnings Lag Estimates

IHS Holding (IHS) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to loss of $0.07 per share a year ago. These figures are

Booz Allen (BAH) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Booz Allen (BAH) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

Analysts on Wall Street project that Booz Allen Hamilton (BAH) will announce quarterly earnings of $1.59 per share in its forthcoming report, representing an increase of 19.4% year over year

REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research
REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research

Regeneron Pharmaceuticals REGN has emerged as the successful bidder in the bankruptcy auction for most of the assets of 23andMe Holding Co., a prominent player in human genetics and biotechnology.

Momentum ETF (MTUM) Hits New 52-Week High
Momentum ETF (MTUM) Hits New 52-Week High

For investors seeking momentum, iShares MSCI USA Momentum Factor ETF MTUM is probably on the radar. The fund just hit a 52-week high and is up about 37% from its 52-week low price of $168.49/share

Coty Trading Cheaper Than Industry: What's the Next Best Move?
Coty Trading Cheaper Than Industry: What's the Next Best Move?

Coty Inc. COTY is currently trading at a discount to its historical and industry benchmarks. COTY stock trades at a forward 12-month price-to-earnings ratio of 10.57, below its median level of 13.30

The Zacks Analyst Blog Highlights Alphabet and Adobe
The Zacks Analyst Blog Highlights Alphabet and Adobe

For Immediate Release

Chicago, IL – May 20, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Buy 3 Wide Moat Stocks With Double-Digit Near-Term Upside Potential
Buy 3 Wide Moat Stocks With Double-Digit Near-Term Upside Potential

The wide moat strategy involves investing in companies that not only lead their industries but are also strategically fortified to maintain dominance in the future. The business models of these

The Zacks Analyst Blog Highlights Walmart, Home Depot, Target, Lowe and TJX
The Zacks Analyst Blog Highlights Walmart, Home Depot, Target, Lowe and TJX

For Immediate Release

Chicago, IL – May 20, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Ionis' Tryngolza Cuts Triglyceride Levels in Late-Stage Study
Ionis' Tryngolza Cuts Triglyceride Levels in Late-Stage Study

Ionis Pharmaceuticals IONS recently announced positive top-line results from the phase III ESSENCE study evaluating its wholly owned drug Tryngolza in people with moderate hypertriglyceridemia who

The Zacks Analyst Blog Highlights Walmart, Palantir Technologies and Uber Technologies
The Zacks Analyst Blog Highlights Walmart, Palantir Technologies and Uber Technologies

For Immediate Release

Chicago, IL – May 20, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Wall Street Cuts Virtu Financial's Outlook: How to Play the Stock?
Wall Street Cuts Virtu Financial's Outlook: How to Play the Stock?

Virtu Financial, Inc. VIRT, a prominent name in the financial services space, is under scrutiny as analysts trim their earnings projections for 2025 and 2026. While the company extended its streak

Should You Continue to Hold Charles River Stock in Your Portfolio?
Should You Continue to Hold Charles River Stock in Your Portfolio?

Charles River Laboratories International, Inc. CRL expands its products and services across the drug discovery and early-stage development continuum through targeted partnerships and acquisitions

Reasons Why Investors Should Hold on to Marsh & McLennan Shares Now
Reasons Why Investors Should Hold on to Marsh & McLennan Shares Now

Marsh & McLennan Companies, Inc. MMC is well-positioned for growth, leveraging strong Marsh and Guy Carpenter businesses and Consulting segment, new business generation and prudent acquisitions

Zacks Industry Outlook Highlights Carnival, Pursuit Attractions and Hospitality and The Marcus
Zacks Industry Outlook Highlights Carnival, Pursuit Attractions and Hospitality and The Marcus

For Immediate Release

Chicago, IL – May 20, 2025 – Today, Zacks Equity Research discusses Carnival Corp. & plc CCL, Pursuit Attractions and Hospitality, Inc. PRSU and The Marcus Corp. MCS.

Industry:

Equinor & Polenergia Greenlight Major Baltic Offshore Wind Project
Equinor & Polenergia Greenlight Major Baltic Offshore Wind Project

Equinor ASA EQNR, a Norwegian integrated energy company, has made a final investment decision, in partnership with Poland’s Polenergia, for an offshore wind project in the Baltic Sea. Polenergia

Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software
Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software

Illumina, Inc. ILMN recently unveiled the DRAGEN version 4.4 software (v4.4), the industry's most comprehensive secondary analysis solution. The latest version includes out-of-the-box oncology

Rio Tinto and Codelco Ink Deal for Major Lithium Development in Chile
Rio Tinto and Codelco Ink Deal for Major Lithium Development in Chile

Rio Tinto Group RIO announced that it has inked a binding agreement with Corporación Nacional Del Cobre de Chile (Codelco) to form a joint venture (JV) for a lithium project in Chile's Salar de

Western Digital Unveils Open Storage Innovations at Computex 2025
Western Digital Unveils Open Storage Innovations at Computex 2025

Western Digital Corporation WDC is driving a new era of storage innovation by advancing infrastructure solutions tailored for artificial intelligence/machine learning (AI/ML), software-defined

Pfizer Buys Rights to PD-1 & VEGF Inhibitor From China Biotech
Pfizer Buys Rights to PD-1 & VEGF Inhibitor From China Biotech

Pfizer PFE announced that it is in-licensing global development and commercialization rights, ex-China, to SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, from Chinese biotech, 3SBio.

3SBio

Zacks Industry Outlook Highlights Allegion, MSA Safety, Life360 and Alarm.com
Zacks Industry Outlook Highlights Allegion, MSA Safety, Life360 and Alarm.com

For Immediate Release

Chicago, IL – May 20, 2025 – Today, Zacks Equity Research discusses Allegion plc ALLE, MSA Safety Inc. MSA, Life360, Inc. LIF and Alarm.com Holdings, Inc. ALRM.

Industry: